{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:45:25Z","timestamp":1790246725137,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004699","name":"Chung Shan Medical University Hospital","doi-asserted-by":"publisher","award":["CSH-2019-C-031"],"award-info":[{"award-number":["CSH-2019-C-031"]}],"id":[{"id":"10.13039\/501100004699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 108-2314-B-040-014-MY3"],"award-info":[{"award-number":["MOST 108-2314-B-040-014-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["106-2314-B-040-026-MY2"],"award-info":[{"award-number":["106-2314-B-040-026-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.canlet.2022.01.007","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T02:27:50Z","timestamp":1642040870000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Chidamide and mitomycin C exert synergistic cytotoxic effects against bladder cancer cells in vitro and suppress tumor growth in a rat bladder cancer model"],"prefix":"10.1016","volume":"530","author":[{"given":"Shao-Chuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Chuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Lang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Wei","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2022.01.007_bib1","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.canlet.2022.01.007_bib2","first-page":"7","volume":"71","author":"Siegel","year":"2021","journal-title":"Cancer Stat."},{"key":"10.1016\/j.canlet.2022.01.007_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(09)60491-8","article-title":"Bladder cancer","volume":"374","author":"Kaufman","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2022.01.007_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","volume":"69","author":"Sylvester","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2022.01.007_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.eururo.2017.06.038","article-title":"Value of an immediate intravesical instillation of mitomycin C in patients with non\u2013muscle-invasive bladder cancer: a prospective multicentre randomised study in 2243 patients","volume":"73","author":"Bosschieter","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2022.01.007_bib6","doi-asserted-by":"crossref","first-page":"35.e15","DOI":"10.1016\/j.urolonc.2013.01.009","article-title":"Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non\u2013muscle invasive bladder cancer","volume":"32","author":"Lightfoot","year":"2014","journal-title":"Urol. Oncol.: Seminars and Original Investigations"},{"key":"10.1016\/j.canlet.2022.01.007_bib7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/bju.13088","article-title":"Intravesical gemcitabine in combination with mitomycin C as salvage treatment in recurrent non-muscle-invasive bladder cancer","volume":"117","author":"Cockerill","year":"2016","journal-title":"BJU Int."},{"key":"10.1016\/j.canlet.2022.01.007_bib8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00280-011-1766-x","article-title":"Chidamide (CS055\/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity","volume":"69","author":"Ning","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2022.01.007_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2147\/OTT.S93528","article-title":"Chidamide in the treatment of peripheral T-cell lymphoma","volume":"10","author":"Chan","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2022.01.007_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13045-017-0439-6","article-title":"Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China","volume":"10","author":"Shi","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2022.01.007_bib11","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/sj.onc.1210610","article-title":"Histone deacetylases and cancer","volume":"26","author":"Glozak","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2022.01.007_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3892\/or.2014.3595","article-title":"Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax\/Bcl-2 and P21 in pancreatic cancer","volume":"33","author":"Zhao","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2022.01.007_bib13","first-page":"3169","article-title":"Chidamide, a novel histone deacetylase inhibitor, inhibits the viability of MDS and AML cells by suppressing JAK2\/STAT3 signaling","volume":"8","author":"Zhao","year":"2016","journal-title":"Am. J. Tourism Res."},{"key":"10.1016\/j.canlet.2022.01.007_bib14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2010.01.011","article-title":"A novel histone deacetylase inhibitor Chidamide induces apoptosis of human colon cancer cells","volume":"392","author":"Liu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2022.01.007_bib15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.phymed.2018.09.218","article-title":"Chidamide-induced ROS accumulation and miR-129-3p-dependent cell cycle arrest in non-small lung cancer cells","volume":"56","author":"Wu","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.canlet.2022.01.007_bib16","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1158\/1078-0432.CCR-12-3439","article-title":"IL-10 promotes tumor aggressiveness via upregulation of CIP2A transcription in lung adenocarcinoma","volume":"19","author":"Sung","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2022.01.007_bib17","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1158\/1078-0432.CCR-11-0227","article-title":"A polymorphic -844T\/C in FasL promoter predicts survival and relapse in non-small cell lung cancer","volume":"17","author":"Sung","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2022.01.007_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.canlet.2022.01.007_bib19","first-page":"884","article-title":"The effect of curcumin on bladder tumor in rat model","volume":"21","author":"Pan","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2022.01.007_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2010.01.011","article-title":"A novel histone deacetylase inhibitor Chidamide induces apoptosis of human colon cancer cells","volume":"392","author":"Liu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2022.01.007_bib21","first-page":"1503","article-title":"Antitumor activity of Chidamide in hepatocellular carcinoma cell lines","volume":"5","author":"Wang","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2022.01.007_bib22","first-page":"7644","article-title":"A combination of low-dose decitabine and chidamide resulted in synergistic effects on the proliferation and apoptosis of human myeloid leukemia cell lines","volume":"11","author":"Xu","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.canlet.2022.01.007_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10637-017-0552-y","article-title":"Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK\/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway","volume":"36","author":"Zhou","year":"2018","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.canlet.2022.01.007_bib24","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/ijc.31199","article-title":"HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma","volume":"142","author":"Gallagher","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2022.01.007_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11010-011-1085-x","article-title":"VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin","volume":"361","author":"Zhang","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.canlet.2022.01.007_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ceb.2006.08.015","article-title":"The case for survivin as a regulator of microtubule dynamics and cell-death decisions","volume":"18","author":"Altieri","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.canlet.2022.01.007_bib27","first-page":"679","article-title":"A novel histone deacetylase inhibitor, induces cell cycle arrest and subsequent apoptosis in refractory human pancreatic cancer cells","volume":"24","author":"Sato","year":"2004","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2022.01.007_bib28","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.3390\/ijms20133259","article-title":"Comparison of radiosensitization by HDAC inhibitors CUDC-101 and SAHA in pancreatic cancer cells","volume":"20","author":"Moertl","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2022.01.007_bib29","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.cdd.4402134","article-title":"Cleavage and degradation of Claspin during apoptosis by caspases and the proteasome","volume":"14","author":"Semple","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2022.01.007_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3892\/etm.2014.1837","article-title":"Current animal models of bladder cancer: awareness of translatability (Review)","volume":"8","author":"Ding","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.canlet.2022.01.007_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0009-2797(73)90031-8","article-title":"Bladder cancer and N-methyl-N-nitrosourea. II. Sub-cellular changes associated with a single noncarcinogenic dose of MNU","volume":"7","author":"Wakefield","year":"1973","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.canlet.2022.01.007_bib32","first-page":"6668","article-title":"Characterization of an N-methyl-N-nitrosourea-induced autochthonous rat bladder cancer model","volume":"50","author":"Steinberg","year":"1990","journal-title":"Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522000155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522000155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:04:19Z","timestamp":1777550659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383522000155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":32,"alternative-id":["S0304383522000155"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2022.01.007","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chidamide and mitomycin C exert synergistic cytotoxic effects against bladder cancer cells in vitro and suppress tumor growth in a rat bladder cancer model","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2022.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}